LEADER 01525nlm0 2200325 450 001 000030415 005 20150326125004.0 100 $a20150326d2013----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay---m---001yy 200 1 $a<>servizi pubblici locali esternalizzati nella dimensione nazionale e locale$ftesi di dottorato di: Sara Sequino$gtutor: Mariano D\2019Amore$brisorsa elettronica 210 $aNapoli$d2013 215 $a1 disco ottico (CD-ROM)$d12 cm 230 $aDati testuali (1 file: 5,60 Mb) 304 $aTit. dell'etichetta 314 $aCoordinatore: Mariano D\2019Amore 328 $aTesi di Dottorato di ricerca in Economia e regolamentazione delle aziende e delle amministrazioni pubbliche. 2011-2013 (25. ciclo) : Università degli studi di Napoli "Parthenope". Dipartimento di Studi Aziendali 337 $aRequisiti minimi del sistema: Windows 500 10$a<>servizi pubblici locali esternalizzati nella dimensione nazionale e locale$940282 610 1 $aServizi pubblici$aFinanziamenti 610 1 $aServizi pubblici$aGestione privata 676 $a338.473636$v21$9Beni e servizi. Servizi pubblici e affini 700 1$aSequino,$bSara$0634503 712 02$aUniversità degli Studi di Napoli "Parthenope" 801 0$aIT$bUNIPARTHENOPE$c20150319$gRICA$2UNIMARC 912 $a000030415 951 $aTESI Dottorato CD-ROM/190$bs.i.$cNAVA1$d2015 996 $aServizi pubblici locali esternalizzati nella dimensione nazionale e locale$940282 997 $aUNIPARTHENOPE LEADER 05372nam 22006854a 450 001 9911019314703321 005 20200520144314.0 010 $a9786611135317 010 $a9781281135315 010 $a1281135313 010 $a9780470517437 010 $a0470517433 010 $a9780470517444 010 $a0470517441 035 $a(CKB)1000000000413971 035 $a(EBL)326413 035 $a(OCoLC)476124182 035 $a(SSID)ssj0000176759 035 $a(PQKBManifestationID)11170150 035 $a(PQKBTitleCode)TC0000176759 035 $a(PQKBWorkID)10206033 035 $a(PQKB)10010364 035 $a(MiAaPQ)EBC326413 035 $a(PPN)188664904 035 $a(Perlego)2762253 035 $a(EXLCZ)991000000000413971 100 $a20070604d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aIminosugars $efrom synthesis to therapeutic applications /$feditors, Philippe Compain and Olivier R. Martin 210 $aChichester, West Sussex, England ;$aHoboken, NJ, USA $cJ. Wiley$dc2007 215 $a1 online resource (487 p.) 300 $aDescription based upon print version of record. 311 08$a9780470033913 311 08$a0470033916 320 $aIncludes bibliographical references and index. 327 $aIminosugars; Contents; Foreword; Preface; List of contributors; 1 Iminosugars: past, present and future; 2 Naturally occurring iminosugars and related alkaloids: structure, activity and applications; 2.1 Introduction; 2.2 -Glucosidase inhibitors; 2.3 -Glucosidase inhibitors; 2.4 - and -Galactosidase inhibitors; 2.5 -Mannosidase inhibitors; 2.6 Concluding remarks and future prospects; References; 3 General strategies for the synthesis of iminosugars and new approaches towards iminosugar libraries; 3.1 Introduction; 3.2 Monocyclic compounds; 3.3 1-N-Iminosugars; 3.4 Bicyclic compounds 327 $a3.5 Other bicyclic compounds3.6 Iminosugar conjugates; 3.7 Conclusions; References; 4 Iminosugar C-glycosides: synthesis and biological activity; 4.1 Introduction; 4.2 Synthesis of iminosugar C-glycosides; 4.3 Biological activity of iminosugar C-glycosides; 4.4 Conclusion; References; 5 Imino-C-disaccharides and analogues: synthesis and biological activity; 5.1 Introduction; 5.2 Synthesis of imino-C-disaccharides; 5.3 Conformations of imino-C-disaccharides; 5.4 Glycosidase inhibitory activities of imino-C-disaccharides 327 $a5.5 Efficient combinatorial method for the discovery of glycosidase inhibitors5.6 Antitumour activity of new -mannosidase inhibitors; 5.7 Conclusion; References; 6 Isofagomine, noeuromycin and other 1-azasugars, iminosugar-related glycosidase inhibitors; 6.1 Introduction; 6.2 1-Azasugars that are piperidines (isofagomine, noeuromycin, etc.); 6.3 1-Azasugars that are hydrazines; 6.4 1-Azasugars that are oxazines; 6.5 1-Azasugars that are piperidones; 6.6 Sulphur-containing analogues of 1-azasugars; 6.7 Slow inhibition and thermodynamics of binding 327 $a6.8 Are 1-azasugars (and iminosugars) transition state analogues?References; 7 Iminosugar-based glycosyltransferase inhibitors; 7.1 Biological role and structural features of glycosyltransferases; 7.2 Development of inhibitors of glycosyltransferases; 7.3 Conclusion; References; 8 Transition state analogue inhibitors of N-ribosyltransferases; 8.1 Introduction; 8.2 Nucleoside hydrolases; 8.3 Purine nucleoside phosphorylases (PNPs); 8.4 5'-Methylthioadenosine (MTA) nucleosidases and phosphorylases; 8.5 Ricin A-chain; References; 9 Iminosugars as antiviral agents; 9.1 Introduction 327 $a9.2 The relationship between glucosidase inhibition and antiviral action9.3 Fate of viral glycoproteins in glucosidase-inhibited cells; 9.4 Specificity of glucosidase inhibition; 9.5 N-Alkyl DNJs inhibit virus growth by non-glucosidase inhibitory mechanisms - other potential activities of these compounds; 9.6 New directions for improving glucosidase inhibitors as antiviral agents; References; 10 Iminosugars as active-site-specific chaperones for the treatment of lysosomal storage disorders; 10.1 Introduction; 10.2 Degradation of glycosphingolipids 327 $a10.3 Lysosomal enzyme biosynthesis and ER-associated degradation (ERAD) 330 $aIminosugars form undoubtedly the most attractive of carbohydrate mimics reported so far. In these structures, the substitution of the endocyclic oxygen of sugars by a basic nitrogen atom leads to remarkable biological properties and raises many challenges in organic synthesis. Since the discovery of their biological activity as glycosidase inhibitors in the 1970's, these polyvalent molecules have progressively made their way from the laboratory to the clinic. The impressive series of discoveries in the field over the past ten years indicates clearly that it is "a boom time" for iminosugar 606 $aImino sugars$xSynthesis 606 $aImino sugars$xTherapeutic use 615 0$aImino sugars$xSynthesis. 615 0$aImino sugars$xTherapeutic use. 676 $a612/.01578 701 $aCompain$b Philippe$01837796 701 $aMartin$b Olivier R$01837797 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019314703321 996 $aIminosugars$94416628 997 $aUNINA